Cytosine is a fundamental nitrogenous base present in both DNA and RNA, playing a critical role in
essential cellular processes such as replication, transcription, gene regulation, signal transduction, and
DNA repair. Due to its central biological importance, the efficient and cost-effective synthesis of cytosine
has garnered significant interest across biochemical, pharmaceutical, and industrial sectors. However,
most conventional synthetic methods rely on complex enzymatic transformations or require expensive
and structurally elaborate starting materials, thereby limiting their practicality for large-scale production.
These challenges result in elevated manufacturing costs and raise sustainability concerns. In contrast, the
synthetic approach presented in this study provides a more economical, scalable, and environmentally
benign alternative for cytosine production. This method employs inexpensive and readily available raw
materials—specifically urea and cyanoacetic acid ester—to construct the cytosine ring system through a
concise and efficient sequence of chemical transformations. The process involves four main steps:
condensation, cyclization, hydrolysis, and decarboxylation. Each step is optimized to minimize byproduct
formation and reduce purification requirements, thereby improving overall yield and process efficiency.
Notably, the use of formic acid in place of triethyl orthoformate significantly reduces material costs and
avoids ethanol formation, which simplifies downstream handling. Moreover, mild reaction conditions and
reduced solvent waste enhance the green chemistry profile of the synthesis. The final product obtained
exhibits high purity (≥99%) and is suitable for pharmaceutical applications. Overall, this synthetic route
offers a practical and sustainable pathway to cytosine, making it suitable for widespread use in nucleic
acid research, drug development, and large-scale nucleobase manufacturing.

🔒 This is a subscription article

Full text is available to subscribers and institutional members. Please choose an option below to access it.

Cytosine is a fundamental nitrogenous base present in both DNA and RNA, playing a critical role in
essential cellular processes such as replication, transcription, gene regulation, signal transduction, and
DNA repair. Due to its central biological importance, the efficient and cost-effective synthesis of cytosine
has garnered significant interest across biochemical, pharmaceutical, and industrial sectors. However,
most conventional synthetic methods rely on complex enzymatic transformations or require expensive
and structurally elaborate starting materials, thereby limiting their practicality for large-scale production.
These challenges result in elevated manufacturing costs and raise sustainability concerns. In contrast, the
synthetic approach presented in this study provides a more economical, scalable, and environmentally
benign alternative for cytosine production. This method employs inexpensive and readily available raw
materials—specifically urea and cyanoacetic acid ester—to construct the cytosine ring system through a
concise and efficient sequence of chemical transformations. The process involves four main steps:
condensation, cyclization, hydrolysis, and decarboxylation. Each step is optimized to minimize byproduct
formation and reduce purification requirements, thereby improving overall yield and process efficiency.
Notably, the use of formic acid in place of triethyl orthoformate significantly reduces material costs and
avoids ethanol formation, which simplifies downstream handling. Moreover, mild reaction conditions and
reduced solvent waste enhance the green chemistry profile of the synthesis. The final product obtained
exhibits high purity (≥99%) and is suitable for pharmaceutical applications. Overall, this synthetic route
offers a practical and sustainable pathway to cytosine, making it suitable for widespread use in nucleic
acid research, drug development, and large-scale nucleobase manufacturing.

🔒 This is a subscription article

Full text is available to subscribers and institutional members. Please choose an option below to access it.